AgeneBio Secures $1,000,113 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    11711 North Meridian Street Carmel, IN 46032
  • Company Description
    AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s disease (AD).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor

Trending on Xconomy